Educational Resources EN2026-03-17T14:11:36+01:00

EDUCATIONAL RESOURCES

Videos

Learn more about the RADIANCE-HTN clinical studies and the Paradise™ Ultrasound Renal Denervation system.

RADIANCE-HTN SOLO Results

About Paradise™ Ultrasound RDN treatment

Summary Paradise™ Ultrasound RDN System

Short Gel-model explanation of Paradise™ Ultrasound RDN System

View more videos on YouTube

View more videos on Radcliffe

Case Reports

Hypertension and Severe Heart Failure

Renal Denervation in a Patient with Hypertension and Severe Heart Failure
Stefan Toggweiler, MD Heart Center Lucerne, Lucerne, Switzerland

Renal denervation ablates sympathetic nerves to lower blood pressure in patients with therapy-resistant hypertension. We report on a patient with hypertension and ischemic cardiomyopathy who did not tolerate his medication. He was treated with combined ultrasound-based renal denervation and CRT implantation. His blood pressure dropped by 60 mmHg and left-ventricular ejection fraction normalized.

Read Case Report

The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted.

© 2026 Recor Medical, Inc. All rights reserved. The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted, per approved indications for use, and received manufacturing and marketing approval in Japan. RECOR MEDICAL, PARADISE, HYDROCOOLING, SONOWAVE 360, RADIANCE, the GPS logo, and the Swirl logo are registered trademarks in the EU and the other countries, RECOR and the RADIANCE logo are also trademarks of Recor Medical, Inc. EMEA 03/2025

Important Safety Information
Prescription Only. Brief Summary – Prior to use, please reference the Instructions for Use

Indications for Use
The Paradise Catheter is indicated for percutaneous renal denervation.

Results may vary. The most common risks include pain, vascular site injury and vasospasm. See full important safety information: https://www.recormedical.eu/paradise-ultrasound-rdn-system/#safety

Recor Medical, headquartered in Palo Alto, California, USA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd. recormedical.eu is Recor Medical, Otsuka Medical Devices Europe GmbH website (the Site). We control and operate this Site from Europe. This Site is intended for use by European residents only and contains information regarding the Paradise™ System, which is approved for sale in the EU and bears a CE mark.

Recor Medical Europe GmbH
Europa-Allee 52 · 60327 Frankfurt · Germany
Amtsgericht Frankfurt am Main: HRB 123214
Chief Executive Officers: Lara Barghout, Michael Jones, Ronan O`Connor

EDUCATIONAL RESOURCES

Videos

Case Reports

Hypertension and Severe Heart Failure

For healthcare professionals only

For healthcare
professionals only